RIA
JAZZ icon

Realta Investment Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Realta Investment Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-46
Closed -$7K – 872
2019
Q4 		$7K Sell
46
-320
-87% -$43.5K ﹤0.01% 1243
2019
Q3 		$47K Sell
366
-270
-42% -$36.2K 0.01% 695
2019
Q2 		$92K Buy
636
+36
+6% +$4.84K 0.03% 521
2019
Q1 		$86K Buy
+600
New +$78.3K 0.04% 425

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Realta Investment Advisors's JAZZ Position: Q1 2020 in Review

Realta Investment Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2020, closing a stake of 46 shares — an estimated $7K sold.

Realta Investment Advisors first reported a position in JAZZ in Q1 2019 and held it in 4 quarters. The position peaked at $92K in Q2 2019. 408 funds tracked by Wall St. Rank hold JAZZ as of Q1 2020.

  • Realta Investment Advisors reported no remaining Jazz Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Realta Investment Advisors sold 46 Jazz Pharmaceuticals shares in Q1 2020, an estimated $7K.
  • Realta Investment Advisors first reported a position in Jazz Pharmaceuticals in Q1 2019 and held it in 4 quarters.
  • Realta Investment Advisors's Jazz Pharmaceuticals position peaked at $92K in Q2 2019.
  • 408 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2020.

Based on Realta Investment Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.